Clinical trial

Heart Failure Optimization Study

NCT03016754

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-03-01

PhaseN/A

Study timeline

Study start (actual)2017-03-01Date precision: day

Registry last updated2025-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sudden Cardiac Deathunresolved

Sudden Cardiac Arrestunresolved

Heart Failureunresolved

Heart Failure Low Outputunresolved

Interventions

Wearable Cardioverter DefibrillatorDEVICE

Sponsors & collaborators

Zoll Medical Corporationlead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States2 HamburgGermany2 MemphisTennessee, United States2 GrenobleFrance2 BostonMassachusetts, United States1 DallasTexas, United States1 St LouisMissouri, United States1 ParisFrance1 BirminghamAlabama, United States1 BerlinGermany1 JacksonvilleFlorida, United States1 OrlandoFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03016754 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.